What Happened
The Director of Nursing at Garfield County Health Center in Jordan, Montana, pleaded guilty to tampering with vials of fentanyl and other controlled substances she was entrusted to safeguard.
On January 19, 2023, staff at Garfield County Health Center entered the defendant's locked office to retrieve a narcotics log and noticed suspicious items, including hospital stock narcotics, an IV pole, tourniquets, needles, IV equipment, replacement vial caps, replacement medication labels, and what appeared to be blood on many surfaces. A subsequent search of the office turned up numerous vials of fentanyl that had been tampered with — caps removed and replaced — or emptied entirely, along with other controlled substances that had been replaced.
Staff reported concerns that patients may have received saline solution instead of pain medication in the months preceding the discovery. A forensic chemist with the Food and Drug Administration analyzed the containers seized from the office and concluded the controlled substances had been tampered with and adulterated. In December 2025, the defendant pleaded guilty to one count of tampering with a consumer product. Sentencing is scheduled for April 15, 2026.
What Went Wrong
The facility's most senior nursing leader was able to stockpile tampering supplies and adulterate controlled substances in her own office for months before discovery. Key failure points:
- No oversight of the director's own drug access. A nursing director's position of authority gave her latitude that ordinary staff would not have had, and nothing in the facility's controls treated her controlled-substance activity differently or subjected it to independent review.
- Tampering supplies went unnoticed for an extended period. Replacement vial caps and labels, along with an IV pole and other administration equipment, were stockpiled in a locked office without anyone questioning why a nursing director needed this equipment outside clinical areas.
- Detection depended on a narcotics-log retrieval, not routine surveillance. The tampering only surfaced because staff needed to retrieve a log from her office — not because of a waste audit, inventory reconciliation, or automated discrepancy report.
- No tamper inspection at the point of care. Patients reportedly received diluted or saline-substituted medication for pain relief without staff noticing before administration.
How It Could Have Been Prevented
- Apply the same controlled-substance access restrictions and audit trails to nursing leadership and management as to front-line staff — authority should not exempt anyone from oversight.
- Reconcile controlled substance dispensing, administration, and waste records against physical inventory on a frequent, scheduled basis rather than relying on incidental discovery.
- Inspect vials for tamper evidence — altered caps, replaced labels, discoloration — at receipt, at dispensing, and before administration.
- Require witnessed waste and witnessed counts for controlled substances, with a documented chain of custody that does not depend on any single employee's office or workspace.
- Train staff to report unusual items or patterns — even in a supervisor's private workspace — without fear of retaliation.
Related Guidance
- Investigation Playbook — How to run an internal diversion investigation when staff or product integrity is questioned.
- 15 Red Flags of Drug Diversion — Behavioral and recordkeeping indicators of diversion, including by supervisory staff.
- Controlled Substance Inventory Guide — Reconciliation, cycle counts, and biennial inventory requirements.
- Hospital Self-Assessment Checklist — Hospital self-assessment, 8 sections and 63 weighted items.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients.